Platform Technology Partners Bristol Myers Squibb CO Transaction History

Platform Technology Partners

$355 Million
Q2 2025

A detailed history of Platform Technology Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Platform Technology Partners holds 23,265 shares of BMY stock, worth $1.01 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

23,265

Previous 23,538 1.16%

Holding current value

$1.01 Million

Previous $1.44 Million 25.02%

% of portfolio

0.3%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$44.12 - $59.6 $12,044 - $16,270	-273 Reduced 1.16%	23,265 $1.08 Million
Q1 2025 May 01, 2025	SELL	$53.9 - $63.11 $35,142 - $41,147	-652 Reduced 2.7%	23,538 $1.44 Million
Q4 2024 Jan 28, 2025	BUY	$51.92 - $59.94 $3,478 - $4,015	67 Added 0.28%	24,190 $1.37 Million
Q3 2024 Nov 04, 2024	SELL	$39.66 - $51.75 $44,141 - $57,597	-1,113 Reduced 4.41%	24,123 $1.25 Million
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $67,217 - $88,493	-1,670 Reduced 6.21%	25,236 $1.05 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $140,979 - $168,227	2,908 Added 12.12%	26,906 $1.38 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $18,409 - $20,584	-318 Reduced 1.31%	23,998 $1.39 Million
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $44,151 - $49,022	-693 Reduced 2.77%	24,316 $1.56 Million
Q1 2023 Apr 04, 2023	SELL	$65.71 - $74.53 $27,598 - $31,302	-420 Reduced 1.65%	25,009 $1.73 Million
Q4 2022 Jan 11, 2023	BUY	$68.48 - $81.09 $20,817 - $24,651	304 Added 1.21%	25,429 $0
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $48 - $28,584	-372 Reduced 1.46%	25,125 $1.79 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $18,735 - $20,634	-258 Reduced 1.0%	25,497 $1.96 Million
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $24,469 - $29,340	-398 Reduced 1.52%	25,755 $1.88 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $30,515 - $35,573	-569 Reduced 2.13%	26,153 $1.63 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $115,914 - $135,778	-1,959 Reduced 6.83%	26,722 $1.58 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $251,354 - $273,725	-4,060 Reduced 12.4%	28,681 $1.92 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $7,332 - $8,309	127 Added 0.39%	32,741 $2.03 Million
Q3 2020 Nov 30, 2020	BUY	$57.43 - $63.64 $93,725 - $103,860	1,632 Added 5.27%	32,614 $1.97 Million
Q2 2020 Nov 30, 2020	BUY	$54.82 - $64.09 $71,704 - $83,829	1,308 Added 4.41%	30,982 $1.82 Million
Q1 2020 Nov 30, 2020	BUY	$46.4 - $67.43 $200,587 - $291,499	4,323 Added 17.05%	29,674 $1.65 Million
Q4 2019 Dec 03, 2020	BUY	$49.21 - $64.19 $1.25 Million - $1.63 Million	25,351 New	25,351 $1.63 Million

Others Institutions Holding BMY

# of Institutions

2,664

Shares Held

1.64B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $92.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Account

Platform Technology Partners Bristol Myers Squibb CO Transaction History